A detailed history of Highlander Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Highlander Capital Management, LLC holds 61,324 shares of PFE stock, worth $1.64 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
61,324
Previous 37,669 62.8%
Holding current value
$1.64 Million
Previous $1.08 Million 56.92%
% of portfolio
0.69%
Previous 0.47%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 20, 2024

BUY
$25.89 - $29.73 $612,427 - $703,263
23,655 Added 62.8%
61,324 $1.7 Million
Q4 2023

Jan 24, 2024

BUY
$26.13 - $33.94 $331,851 - $431,038
12,700 Added 50.86%
37,669 $1.08 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $274,882 - $321,310
8,566 Added 52.22%
24,969 $828,000
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $10,836 - $12,537
-300 Reduced 1.8%
16,403 $601,000
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $24,068 - $29,381
-550 Reduced 3.19%
16,703 $731,000
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $6,979 - $8,275
150 Added 0.88%
17,253 $905,000
Q1 2022

May 09, 2022

SELL
$45.75 - $56.69 $27,450 - $34,014
-600 Reduced 3.39%
17,103 $885,000
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $2,066 - $3,062
-50 Reduced 0.28%
17,703 $1.05 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $195,916 - $220,954
-5,850 Reduced 24.78%
17,753 $643,000
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $200,820 - $255,360
-6,000 Reduced 20.27%
23,603 $869,000
Q3 2020

Nov 17, 2020

SELL
$31.75 - $37.25 $1,587 - $1,862
-50 Reduced 0.17%
29,603 $1.09 Million
Q2 2020

Aug 17, 2020

BUY
$30.12 - $36.54 $399,090 - $484,155
13,250 Added 80.78%
29,653 $970,000
Q1 2020

May 27, 2020

BUY
$27.03 - $38.62 $2,703 - $3,861
100 Added 0.61%
16,403 $535,000
Q4 2019

Feb 13, 2020

SELL
$32.92 - $37.36 $16,460 - $18,680
-500 Reduced 2.98%
16,303 $639,000
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $38,988 - $50,556
-1,200 Reduced 6.67%
16,803 $604,000
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $15,000 - $16,480
-400 Reduced 2.17%
18,003 $765,000
Q3 2018

Nov 09, 2018

SELL
$34.47 - $41.81 $8,617 - $10,452
-250 Reduced 1.34%
18,403 $811,000
Q1 2018

May 16, 2018

BUY
$31.91 - $37.02 $139,925 - $162,332
4,385 Added 30.73%
18,653 $648,000
Q4 2017

Feb 13, 2018

SELL
$33.26 - $35.29 $6,652 - $7,058
-200 Reduced 1.38%
14,268 $517,000
Q3 2017

Nov 15, 2017

BUY
$31.0 - $34.15 $448,508 - $494,082
14,468
14,468 $517,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Highlander Capital Management, LLC Portfolio

Follow Highlander Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highlander Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highlander Capital Management, LLC with notifications on news.